serw-MX  [xml]  
 


    
 DeCS Categories

C05 Musculoskeletal Diseases .
C05.116 Bone Diseases .
C05.116.099 Bone Diseases, Developmental .
C05.116.099.708 Osteochondrodysplasias .
C05.116.099.708.779 Pycnodysostosis .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.490 Epilepsy .
C10.228.140.490.375 Epilepsy, Generalized .
C10.228.140.490.375.260 Epilepsy, Absence .
C10.228.140.490.493 Epileptic Syndromes .
C10.228.140.490.493.125 Epilepsy, Absence .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.595 Lysosomal Storage Diseases .
C16.320.565.595.800 Pycnodysostosis .
C16.320.812 Pycnodysostosis .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.595 Lysosomal Storage Diseases .
C18.452.648.595.800 Pycnodysostosis .
D02 Organic Chemicals .
D02.478 Imides .
D02.478.770 Succinimides .
D02.478.770.333 Ethosuximide .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.773 Pyrrolidines .
D03.383.773.812 Pyrrolidinones .
D03.383.773.812.852 Succinimides .
D03.383.773.812.852.333 Ethosuximide .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.913 Transferases .
D08.811.913.696 Phosphotransferases .
D08.811.913.696.620 Phosphotransferases (Alcohol Group Acceptor) .
D08.811.913.696.620.682 Protein Kinases .
D08.811.913.696.620.682.725 Protein-Tyrosine Kinases .
D08.811.913.696.620.682.725.049 Focal Adhesion Protein-Tyrosine Kinases .
D08.811.913.696.620.682.725.049.750 Focal Adhesion Kinase 2 .
D23 Biological Factors .
D23.050 Antigens .
D23.050.301 Antigens, Surface .
D23.050.301.500 Histocompatibility Antigens .
D23.050.301.500.600 Minor Histocompatibility Antigens .
D23.050.301.500.600.350 Focal Adhesion Kinase 2 .
D23.050.705 Isoantigens .
D23.050.705.552 Histocompatibility Antigens .
D23.050.705.552.600 Minor Histocompatibility Antigens .
D23.050.705.552.600.350 Focal Adhesion Kinase 2 .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Epilepsy, Absence .
Absence Seizure Disorder .
Childhood Absence Epilepsy .
Epilepsy Juvenile Absence .
Epilepsy, Absence, Atypical .
Epilepsy, Petit Mal .
Juvenile Absence Epilepsy .
Pykno-Epilepsy .
Seizure Disorder, Absence .
Absence Epilepsies, Childhood .
Absence Epilepsies, Juvenile .
Absence Epilepsy .
Absence Epilepsy, Childhood .
Absence Epilepsy, Juvenile .
Absence Seizure Disorders .
Childhood Absence Epilepsies .
Epilepsies, Childhood Absence .
Epilepsies, Juvenile Absence .
Epilepsy Juvenile Absences .
Epilepsy, Childhood Absence .
Epilepsy, Juvenile Absence .
Juvenile Absence Epilepsies .
Juvenile Absence, Epilepsy .
Juvenile Absences, Epilepsy .
Minor Epilepsies .
Minor Epilepsy .
Petit Mal Epilepsies .
Petit Mal, Akinetic .
Pykno Epilepsy .
Pykno-Epilepsies .
Pyknolepsies .
Seizure Disorders, Absence .
Akinetic Petit Mal .
Pyknolepsy .
Petit Mal Epilepsy .
Epilepsy, Minor .
EPILEPSY, PETIT MAL .
A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736) .
1.00
563336
 
Ethosuximide .
Emeside .
Ethylmethylsuccimide .
Ethymal .
Etosuximida Faes .
Petnidan .
Pyknolepsinum .
Suksilep .
Suxilep .
Zarontin .
Faes, Etosuximida .
Ethosuccimid .
An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. .
0.86
11854
 
Pycnodysostosis .
Pycnodysostoses .
Pyknodysostoses .
Pyknodysostosis .
Rare autosomal recessive syndrome characterized by delayed closing of CRANIAL SUTURES, short stature, ACRO-OSTEOLYSIS of distal phalanges, dental and MAXILLOFACIAL ABNORMALITIES and an increase in bone density that results in frequent BONE FRACTURES. It is associated with BONE RESORPTION defect due to mutations in the lysosomal cysteine protease CATHEPSIN K. .
0.60
454
 
Focal Adhesion Kinase 2 .
CADTK Protein .
Calcium-Dependent Protein Tyrosine Kinase .
Cell Adhesion Kinase Beta .
FAK Autokinase .
Focal Adhesion Kinase Autokinase .
PYK2 Protein Tyrosine Kinase .
Proline-Rich Tyrosine Kinase 2 .
Protein Tyrosine Kinase PYK2 .
RAFTK Protein .
Related Adhesion Focal Tyrosine Kinase .
Calcium Dependent Protein Tyrosine Kinase .
Proline Rich Tyrosine Kinase 2 .
A non-receptor protein-tyrosine kinase that is expressed primarily in the BRAIN; OSTEOBLASTS; and LYMPHOID CELLS. In the CENTRAL NERVOUS SYSTEM focal adhesion kinase 2 modulates ION CHANNEL function and MITOGEN-ACTIVATED PROTEIN KINASES activity. .
0.35
0851